Acetaminophen

Alternative names

5-lipoxygenase activating protein, AHH, AL5AP_HUMAN, ALOX 5AP, Arachidonate 5-lipoxygenase-activating protein, Aryl hydrocarbon hydroxylase, CA 1, CA 12, CA 13, CA 14, CA 2, CA 7, CA IV, CA-I, CA-II, CA-III, CA-VII, CA-XII, CA-XIII, CA-XIV, CA13 carbonic anhydrase XIII, CA4, CAB, CAC, CAH12_HUMAN, CAH13_HUMAN, CAH14_HUMAN, CAH1_HUMAN, CAH2_HUMAN, CAH4_HUMAN, CAH7_HUMAN, CP11, CP1A1_HUMAN, CYP 1, CYPIA1, Car 1, Car 2, Car3, Car4, Carbonate dehydratase I, Carbonate dehydratase II, Carbonate dehydratase III, Carbonate dehydratase IV, Carbonate dehydratase VII, Carbonate dehydratase XII, Carbonate dehydratase XIII, Carbonate dehydratase XIV, Carbonic anhydrase 1, Carbonic anhydrase 12, Carbonic anhydrase 13, Carbonic anhydrase 14, Carbonic anhydrase 2, Carbonic anhydrase 3, Carbonic anhydrase 4, Carbonic anhydrase 7, Carbonic anhydrase A, Carbonic anhydrase B, Carbonic anhydrase B, formerly, Carbonic anhydrase C, Carbonic anhydrase C, formerly, Carbonic anhydrase I, Carbonic anhydrase II, Carbonic anhydrase III muscle specific, Carbonic anhydrase VII, Carbonic anhydrase XII, Carbonic anhydrase XIII, Carbonic anhydrase XIV, Carbonic dehydratase, Carbonic dehydratase IV, Carbonic dehydratase VII, Cyclooxygenase, Cyclooxygenase 2b, Cyclooxygenase-2, Cytochrome P1 450 dioxin inducible, Cytochrome P1-450, Cytochrome P450 1A1, Cytochrome P450 family 1 subfamily A polypeptide 1, Cytochrome P450 form 6, Cytochrome P450 subfamily I (aromatic compound inducible) polypeptide 1, Cytochrome P450-C, Cytochrome P450-P1, EC 1.14.99.1, EC 4.2.1.1, EC=4.2.1.1, ECK0125, Epididymis secretory protein Li 282, FLJ00280, FLJ00318, FLJ16020, FLJ16733, FLJ20151, Five lipoxygenase activating protein, GRIPGHS, Glucocorticoid-regulated inflammatory Prostaglandin G/H synthase, Glucocorticoid-regulated inflammatory cyclooxygenase, HEL-76, HEL-S-282, HsT18816, JW0122, MB, MGC102720, MGC13548, MK-886-binding protein, MYG_HUMAN, Macrophage activation-associated marker protein P71/73, Microsomal monooxygenase, Myoglobin, NR1B1, NR2B1, Nuclear mitotic apparatus protein retinoic acid receptor alpha fusion protein, Nuclear receptor subfamily 1 group B member 1, Nuclear receptor subfamily 2 group B member 1, Nucleophosmin retinoic acid receptor alpha fusion protein NPM RAR long form, OTTHUMP00000022510, OTTHUMP00000033524, P1 450, P450 C, P450 P1, P450 form 6, P450DX, PES-2, PGG/HS, PGH synthase 2, PGH2_HUMAN, PGHS-2, PHS 2, PHS II, PTGS2, Prostaglandin G/H synthase, Prostaglandin G/H synthase 2, Prostaglandin G/H synthase 2 precursor, Prostaglandin G/H synthase and cyclooxygenase, Prostaglandin H2 synthase 2, Prostaglandin-endoperoxide synthase 2, RAR, RAR-alpha, RARA_HUMAN, RARalpha1, RP17, RXR alpha1, RXRA_HUMAN, Retinitis pigmentosa 17 (autosomal dominant), Retinoic acid nuclear receptor alpha variant 1, Retinoic acid nuclear receptor alpha variant 2, Retinoic acid receptor RXR-alpha, Retinoic acid receptor alpha, Retinoic acid receptor alpha polypeptide, Retinoid X nuclear receptor alpha, Retinoid X receptor alpha, T18816, TIS10, TIS10 protein, Tumor antigen HOM-RCC-3.1.3, UNQ690/PRO1335, Xenobiotic monooxygenase, epididymis luminal protein 76, fj02a10, flavoprotein-linked monooxygenase, hCox 2, prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase), ptgs2a, unp1239, wu:fj02a10, yadF